Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel ® therapy: A randomized, placebo-controlled, multicenter study with a 52 week open extension

Shlomo Melmed, David Cook, Jochen Schopohl, Miklos I. Goth, Karen S.L. Lam, Josef Marek

Research output: Contribution to journalArticle

89 Citations (Scopus)

Fingerprint Dive into the research topics of 'Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel <sup>®</sup> therapy: A randomized, placebo-controlled, multicenter study with a 52 week open extension'. Together they form a unique fingerprint.

Medicine & Life Sciences